Another email from Leo shared by Wild4ctix this mo
Post# of 72440
Posted On: 12/10/2015 1:11:43 PM
Another email from Leo shared by Wild4ctix this morning:
"I believe that the $2 share price is the only issue standing in our way to uplist. Our existing agreement with Aspire Capital allows us to meet the capital requirements. Important: It is up to Nasdaq's sole discretion if they will allow us to be on Nasdaq."
"I believe that the $2 share price is the only issue standing in our way to uplist. Our existing agreement with Aspire Capital allows us to meet the capital requirements. Important: It is up to Nasdaq's sole discretion if they will allow us to be on Nasdaq."
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼